Clinical Trials Logo

Pregnancy Related clinical trials

View clinical trials related to Pregnancy Related.

Filter by:

NCT ID: NCT04601987 Active, not recruiting - Pregnancy Related Clinical Trials

Healthy Moms: Prenatal Counseling for Postpartum Health

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

See https://studypages.com/s/healthy-moms-study-765273 This individual-level randomized trial involves pregnant women followed for at least 6 months after delivery, to compare the effects of providing two "attention-control" counseling interventions designed to increase pregnant women's awareness of either: 1. the maternal health benefits of breastfeeding, or 2. the health benefits of smoke-free homes

NCT ID: NCT04598347 Recruiting - Covid19 Clinical Trials

Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19

Start date: August 8, 2020
Phase:
Study type: Observational [Patient Registry]

Longitudinal prospective study in pregnant women withpositive serology or PCR for SARS-CoV-2 and indicationinvasive technique (amniocentesis or chorionic biopsy) that has the objective to evaluate the possible vertical transmission of SARS-CoV-2in the amniotic fluid or chorionic villi of pregnant women affected by coronavirus in the different periods of gestation.

NCT ID: NCT04597528 Completed - Pregnancy Related Clinical Trials

Elective Induction of Labour at Thirty Nine Weeks: a Prospective Observational Study

EIOL39
Start date: October 17, 2019
Phase:
Study type: Observational

Adverse events are considered to increase in pregnancies extending beyond 39 weeks. For multiparous patients, especially those with a favourable cervix, it is perhaps easy to justify an elective induction at 39 weeks given the low risk of caesarean section. However, for nulliparous patients the current evidence, derived mainly from retrospective observational studies, does not allow a clear recommendation with the exception perhaps of the recent A Randomized Trial of Induction Versus Expectant Management (ARRIVE) trial. Given the reported increased risks of adverse events in pregnancies extending beyond 39 weeks it has been hypothesized that a policy of planned elective induction at 39 weeks could improve outcomes for the infant and the mother. There is a trend towards an increased rate of elective labour induction in pregnancies at 39 weeks, indicating that practitioners are more commonly using elective induction at this gestational age. The practice in India varies slightly from institute to institute. The investigator intend to study the maternal and perinatal outcome, after elective induction of labour, at thirty nine weeks and zero days upto thirty nine and six days, amongst nulliparous singleton pregnancies followed up for the duration of their hospital stay, in Jubilee Mission Medical College and Research Institute (JMMC and RI).

NCT ID: NCT04594070 Terminated - Pregnancy Related Clinical Trials

Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

Start date: October 27, 2020
Phase: Phase 4
Study type: Interventional

The target population for our study is pregnant women in the first or second trimester with a diagnosis of iron deficiency anemia. If a subject is eligible, written consent will be obtained by person to person contact. Eligible participants will be randomized to receive either daily oral iron supplementation or every other day oral iron supplementation.

NCT ID: NCT04590092 Recruiting - Pregnancy Related Clinical Trials

Pessary Use for Stress Urinary Incontinence in Pregnancy

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

When women are pregnant they are more likely to leak urine which can severely affect their quality of life. This problem could be fixed by using a pessary. A pessary is a silicone ring that goes into the vagina which can stop or improve urinary leakage. These devices have been safely used for hundreds of years. However, pessaries has not been studied for urinary leakage in pregnancy. The investigators would like to compare severity of urinary leakage using a number of questionnaires during the last 3 months of pregnancy for women using a pessary versus women without a pessary.

NCT ID: NCT04588467 Completed - Pregnancy Related Clinical Trials

Treatment of Thrombosed Haemorrhoids in Pregnancy

Start date: January 2, 2019
Phase: N/A
Study type: Interventional

Thrombosis of the external hemorrhoids (TEH) is one of the most frequent complain during pregnancy, particularly during the third trimester. The paucity of the medical literature on this topic has recently been underlined in the European guidelines for hemorrhoid treatment . The aim of this prospective study is to compare the efficacy and safety of conservative versus surgical treatment of TEH in pregnant women

NCT ID: NCT04586348 Active, not recruiting - Pregnancy Related Clinical Trials

Prenatal Iodine Supplementation and Early Childhood Neurodevelopment

PoppiE
Start date: January 18, 2021
Phase: Phase 4
Study type: Interventional

A randomized controlled trial to determine the effect of reducing iodine from vitamin and mineral supplements for pregnant women who have adequate iodine intakes (>165 μg/d from food alone) on cognitive development of children at 24 months of age.

NCT ID: NCT04579822 Not yet recruiting - Pregnancy Related Clinical Trials

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Start date: October 1, 2020
Phase:
Study type: Observational

This is a nationwide cohort study to assess maternal and fetal outcomes following vaccination with a quadrivalent influenza vaccine (QIV) during pregnancy.

NCT ID: NCT04572178 Recruiting - Smoking Cessation Clinical Trials

Cash Payment and Counseling During Pregnancy

MARS
Start date: September 15, 2020
Phase: N/A
Study type: Interventional

Smoking during pregnancy has harmful effects on both mother and unborn child. Studies have shown that small rewards can help smokers to quit. In our current study, we ask how such rewards are most effective in supporting smoking cessation in pregnancy.

NCT ID: NCT04569890 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Treatment of Pregnancy RA

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

It is important to control the disease of pregnant women with rheumatoid arthritis to ensure the fetal and maternal health. Frequent disease flare can increase the risk of adverse pregnancy outcomes, including abortion, premature delivery and low birth weight. However, there is no scientific and standardized treatment strategy for RA during pregnancy. About 50% of RA patients need treatment during pregnancy. Tumor necrosis inhibitor (TNFi) is an effective treatment, which can significantly improve the symptoms of RA during pregnancy. However, in order to avoid placental metastasis, TNFi is usually stopped in early pregnancy. Certolizumab pegol (CZP) is a PEGylated, Fc-free TNFi, which does not bind FcRn and is consequently not expected to undergo FcRn-mediated transfer across the placenta. Therefore, it can not transfer through placenta into FcRn and is approved to treat RA during pregnancy. This study focuses on patients with RA who consider pregnancy. We compared the efficacy, safety and economy of CZP and glucocorticoids combined with hydroxychloroquine by a randomized controlled trial.